Catalyst Wire Dossier Catalyst Wire Dossier

NX9

· Nextrast, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NX9, covering 2022-01-18 to 2022-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of NX9 for Delineation of Bowel Anatomy [Phase 2]

See pricing